Amphastar Pharmaceuticals Inc

NASDAQ:AMPH  
47.57
+1.28 (+2.76%)
6:24:53 PM EDT: $48.50 +0.93 (+1.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.38B
Current PE14.29
Forward PE 11.98
2yr Forward PE 10.89
See more stats
Estimates Current Quarter
Revenue$194.79 Million
Adjusted EPS$1.01
See more estimates
10-Day MA$46.97
50-Day MA$46.24
200-Day MA$45.89
See more pivots

Amphastar Pharmaceuticals Inc Stock, NASDAQ:AMPH

11570 6th Street, Rancho Cucamonga, California 91730
United States of America
Phone: +1.909.980.9484
Number of Employees: 1761

Description

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.